Quarterly turnover from adrenergic receptor agonists in Denmark 2018

This statistic shows the quarterly turnover from adrenergic receptor agonists, used to treat respiratory and pulmonary disease, in Denmark in 2018. The highest turnover during 2018 was in the second quarter, which amounted to 193.3 million Danish kroner.

Turnover from adrenergic receptor agonists in Denmark from 1st quarter to 4th quarter 2018

Turnover in million DKK
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Denmark

Survey time period

Q1 to Q4 2018

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Respiratory disease in Sweden "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.